PTX3 and adenocarcinoma: Although the mechanism of action for this structure remains unclear, a molecular study indicated that the overexpression of PTX3 at the N terminus can considerably inhibit the oncogenic activity of transgenic adenocarcinoma mouse prostate-C2 transfectants, whereas C-terminal overexpression has only a minor effect on tumor growth (60).